Lincoln Pharmaceuticals Limited (LINCOLN.NS)
INR 873.9
(1.21%)
INR 873.9
(1.21%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 5.8 Billion | 5.1 Billion | 4.68 Billion | 4.14 Billion | 3.76 Billion | 3.56 Billion |
| Cost of Revenue | 3.91 Billion | 2.41 Billion | 2.19 Billion | 1.98 Billion | 1.83 Billion | 1.76 Billion |
| Gross Profit | 1.88 Billion | 2.68 Billion | 2.48 Billion | 2.15 Billion | 1.93 Billion | 1.8 Billion |
| Operating Expenses | 1.07 Billion | 1.88 Billion | 1.6 Billion | 1.36 Billion | 1.32 Billion | 1.19 Billion |
| Selling, General and Administrative Expenses | 1.07 Billion | 981.38 Million | 429.73 Million | 367.36 Million | 357.8 Million | 284.54 Million |
| Research and Development Expenses | - | 117.69 Million | - | 93.63 Million | 82.99 Million | 89.38 Million |
| Other Expenses | - | 224.72 Million | 99.97 Million | 56.63 Million | 11 Thousand | 160.3 Thousand |
| Cost and Expenses | 3.89 Billion | 4.3 Billion | 3.79 Billion | 3.35 Billion | 3.16 Billion | 2.95 Billion |
| Operating Income | 1.9 Billion | 805.46 Million | 876.97 Million | 798 Million | 583.38 Million | 608.2 Million |
| Interest Expense | 14.64 Million | 20.3 Million | 9.19 Million | 12.02 Million | 14.97 Million | 31.15 Million |
| Income Tax Expense | 289.37 Million | 275.8 Million | 265.84 Million | 214.7 Million | 157.66 Million | 134.55 Million |
| Earnings before Tax | 1.22 Billion | 1 Billion | 959.39 Million | 837.2 Million | 672.32 Million | 621.94 Million |
| Net Income | 933.04 Million | 728.99 Million | 693.55 Million | 622.5 Million | 514.39 Million | 487.1 Million |
| Earnings Per Share Basic | 46.58 | 36.40 | 34.63 | 31.08 | 25.72 | 24.36 |
| Earnings Per Share Diluted | 46.58 | 36.40 | 34.63 | 31.08 | 25.72 | 24.36 |
| Weighted Average Shares Outstanding | 20.03 Million | 20.02 Million | 20.02 Million | 20.02 Million | 20 Million | 20 Million |
| Weighted Average Shares Outstanding (Diluted) | 20.02 Million | 20.02 Million | 20.02 Million | 20.02 Million | 20 Million | 20 Million |
| Gross Margin | 0.33 | 0.53 | 0.53 | 0.52 | 0.51 | 0.51 |
| EBIT Margin | 0.23 | 0.22 | 0.22 | 0.22 | 0.20 | 0.20 |
| Profit Margin | 0.16 | 0.14 | 0.15 | 0.15 | 0.14 | 0.14 |
| EBITDA | 1.34 Billion | 1.11 Billion | 1.05 Billion | 928.42 Million | 765.76 Million | 728.92 Million |
| Earnings Before Tax Margin | 0.33 | 0.16 | 0.19 | 0.19 | 0.15 | 0.17 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.47 Billion | 5.8 Billion | 1.42 Billion | 1.46 Billion | 1.55 Billion | 1.35 Billion |
| Cost of Revenue | 1.02 Billion | 3.91 Billion | 1.01 Billion | 963.4 Million | 738.27 Million | 638.44 Million |
| Gross Profit | 447.99 Million | 1.88 Billion | 411.77 Million | 501.08 Million | 821.6 Million | 717.75 Million |
| Operating Expenses | 252.91 Million | 994.01 Million | 254.8 Million | 232.61 Million | 535.92 Million | 536.02 Million |
| Selling, General and Administrative Expenses | 252.91 Million | - | 254.8 Million | 232.61 Million | 260.72 Million | 264.7 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 104.09 Million | 344.22 Million | 70.19 Million | 110.17 Million | 86.94 Million | 76.9 Million |
| Cost and Expenses | 1.27 Billion | 4.91 Billion | 1.26 Billion | 1.19 Billion | 1.27 Billion | 1.17 Billion |
| Operating Income | 195.07 Million | 892.85 Million | 156.97 Million | 268.47 Million | 372.62 Million | 181.72 Million |
| Interest Expense | 4.39 Million | 14.64 Million | 4.99 Million | 1.54 Million | 3.94 Million | 4.16 Million |
| Income Tax Expense | 58.06 Million | 289.37 Million | 36.2 Million | 96.7 Million | 92.14 Million | 64.33 Million |
| Earnings before Tax | 294.77 Million | 1.22 Billion | 222.17 Million | 377.1 Million | 368.68 Million | 254.46 Million |
| Net Income | 236.71 Million | 933.04 Million | 185.97 Million | 280.4 Million | 276.54 Million | 190.13 Million |
| Earnings Per Share Basic | 11.82 | - | 9.28 | 14.00 | 13.81 | 9.49 |
| Earnings Per Share Diluted | 11.82 | - | 9.28 | 14.00 | 13.81 | 9.49 |
| Weighted Average Shares Outstanding | 20.02 Million | 20.02 Million | 20.02 Million | 20.02 Million | 20.02 Million | 20.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 20.02 Million | 20.02 Million | 20.02 Million | 20.02 Million | 20.02 Million | 20.02 Million |
| Gross Margin | 0.30 | 0.33 | 0.29 | 0.34 | 0.53 | 0.53 |
| EBIT Margin | 0.15 | - | 0.13 | 0.20 | 0.26 | 0.21 |
| Profit Margin | 0.16 | 0.16 | 0.13 | 0.19 | 0.18 | 0.14 |
| EBITDA | 227.32 Million | - | 183.83 Million | 296.61 Million | 398.42 Million | 284.08 Million |
| Earnings Before Tax Margin | 0.13 | 0.15 | 0.11 | 0.18 | 0.24 | 0.13 |
603112
RKUNY
ANGELONE
000822
PKIUF
301588